About the Authors

Barry S. Peters

Barry.Peters@kcl.ac.uk

Affiliations Department of Infectious Diseases, Kings College London, London, United Kingdom, Honorary Consultant Physician, Guys and St Thomas’ Foundation Hospitals, London, United Kingdom

Melissa Perry

Affiliation Department of HIV and GU Medicine Physician, Guys and St Thomas’ Foundation Hospitals, London, United Kingdom

Anthony S. Wierzbicki

Affiliation Department of Chemical Pathology, Guys and St Thomas’ Foundation Hospitals, London, United Kingdom

Lisa E. Wolber

Affiliation Twins Research Unit, Department of Rheumatology, Kings College London, London, United Kingdom

Glen M. Blake

Affiliation Department of Nuclear Medicine, Kings College London, London, United Kingdom

Nishma Patel

Affiliation Department of Infectious Diseases, Kings College London, London, United Kingdom

Richard Hoile

Affiliation School of Medicine, Kings College London, London, United Kingdom

Alastair Duncan

Affiliation Department of Dietetics, Guys and St Thomas’ Foundation Hospitals, London, United Kingdom

Ranjababu Kulasegaram

Affiliation Department of HIV and GU Medicine, Guys and St Thomas’ NHS Trust, London, United Kingdom

Frances M. K. Williams

Affiliation Twins Research Unit, Department of Rheumatology, Kings College London, London, United Kingdom

Competing Interests

The authors have the following interests. Within the past 36 months, the following financial relationships are disclosed for the authors: BSP: received a total for less than $1500 USD, for an advisory board in past 36 months from Abbott Laboratories, GlaxoSmithKline, Merck, & ViiV pharmaceuticals. Grants from GlaxoSmithKline awarded to Dr Peters as above for this study, and as above, a grant from ViiV for a follow-up study on this cohort. Conference attendance funded by Abbott Laboratories for attendance IAS (International AIDS Conference) 2012. RK: received grants, travel sponsorship, research support, or consultancy fees, or has served on advisory boards for ViiV, Merck Sharp & Dohme, Abbott, Bristol-Myers Squibb, Janssen, and Gilead Sciences. The other authors have stated that there have been no financial or other relevant relationships or conflicts of interest within the previous 36 months. This project was in part supported by an unrestricted educational grant from GlaxoSmithKline pharmaceuticals. A subsequent unrestricted grant to look at prospective follow-up of patients described in this manuscript has been granted by ViiV pharmaceuticals and is in progress. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.

Author Contributions

Conceived and designed the experiments: BP AW FW RK. Performed the experiments: BP MP NP RK RH AD. Analyzed the data: BP AW GB LW FW. Contributed reagents/materials/analysis tools: LW GB. Wrote the manuscript: BP FW LW AW FW GB NP AD.